The BioPharm Brief: Data-Driven Trial Design and Bispecific Checkpoint Immunotherapy Advance Oncology Development

In today’s podcast, integrated biomarker modeling and dual-pathway immune checkpoint modulation highlight evolving strategies to improve translational efficiency and durability in oncology trials.